244 related articles for article (PubMed ID: 30288660)
21. Abscisic acid ameliorates oxidative stress, inflammation, and apoptosis in thioacetamide-induced hepatic fibrosis by regulating the NF-кB signaling pathway in mice.
Chen X; Ding C; Liu W; Liu X; Zhao Y; Zheng Y; Dong L; Khatoon S; Hao M; Peng X; Zhang Y; Chen H
Eur J Pharmacol; 2021 Jan; 891():173652. PubMed ID: 33069671
[TBL] [Abstract][Full Text] [Related]
22. Detrimental effects of nicotine on thioacetamide-induced liver injury in mice.
Zhou Z; Park S; Kim JW; Zhao J; Lee MY; Choi KC; Lim CW; Kim B
Toxicol Mech Methods; 2017 Sep; 27(7):501-510. PubMed ID: 28440100
[TBL] [Abstract][Full Text] [Related]
23. Long-Term, Low-Dose Exposure to Microcystin-LR Does not Cause or Increase the Severity of Liver Disease in Rodents.
Labine M; Gong Y; Minuk GY
Ann Hepatol; 2017 November-December,; 16(6):959-965. PubMed ID: 29055933
[TBL] [Abstract][Full Text] [Related]
24. Caffeine prevents experimental liver fibrosis by blocking the expression of TGF-β.
Arauz J; Zarco N; Segovia J; Shibayama M; Tsutsumi V; Muriel P
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):164-73. PubMed ID: 23903851
[TBL] [Abstract][Full Text] [Related]
25. Glycyrrhizic acid inhibits apoptosis and fibrosis in carbon-tetrachloride-induced rat liver injury.
Liang B; Guo XL; Jin J; Ma YC; Feng ZQ
World J Gastroenterol; 2015 May; 21(17):5271-80. PubMed ID: 25954100
[TBL] [Abstract][Full Text] [Related]
26. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway.
Cai S; Wu L; Yuan S; Liu G; Wang Y; Fang L; Xu D
Eur J Pharmacol; 2021 May; 898():173982. PubMed ID: 33647257
[TBL] [Abstract][Full Text] [Related]
27. Antagonism of Interleukin-17A ameliorates experimental hepatic fibrosis by restoring the IL-10/STAT3-suppressed autophagy in hepatocytes.
Zhang XW; Mi S; Li Z; Zhou JC; Xie J; Hua F; Li K; Cui B; Lv XX; Yu JJ; Hu ZW
Oncotarget; 2017 Feb; 8(6):9922-9934. PubMed ID: 28039485
[TBL] [Abstract][Full Text] [Related]
28. Role of differentiation of liver sinusoidal endothelial cells in progression and regression of hepatic fibrosis in rats.
Xie G; Wang X; Wang L; Wang L; Atkinson RD; Kanel GC; Gaarde WA; Deleve LD
Gastroenterology; 2012 Apr; 142(4):918-927.e6. PubMed ID: 22178212
[TBL] [Abstract][Full Text] [Related]
29. Hepatoprotection of silymarin against thioacetamide-induced chronic liver fibrosis.
Chen IS; Chen YC; Chou CH; Chuang RF; Sheen LY; Chiu CH
J Sci Food Agric; 2012 May; 92(7):1441-7. PubMed ID: 22102319
[TBL] [Abstract][Full Text] [Related]
30. Curcumin downregulates Smad pathways and reduces hepatic stellate cells activation in experimental fibrosis.
Hernández-Aquino E; Quezada-Ramírez MA; Silva-Olivares A; Ramos-Tovar E; Flores-Beltrán RE; Segovia J; Shibayama M; Muriel P
Ann Hepatol; 2020; 19(5):497-506. PubMed ID: 32673649
[TBL] [Abstract][Full Text] [Related]
31. Propranolol prevents liver cirrhosis by inhibiting hepatic stellate cell activation mediated by the PDGFR/Akt pathway.
Ding Q; Li Z; Liu B; Ling L; Tian X; Zhang C
Hum Pathol; 2018 Jun; 76():37-46. PubMed ID: 29514109
[TBL] [Abstract][Full Text] [Related]
32. Glibenclamide protects against thioacetamide-induced hepatic damage in Wistar rat: investigation on NLRP3, MMP-2, and stellate cell activation.
Dwivedi DK; Jena GB
Naunyn Schmiedebergs Arch Pharmacol; 2018 Nov; 391(11):1257-1274. PubMed ID: 30066023
[TBL] [Abstract][Full Text] [Related]
33. Prevention of liver cirrhosis in rats by curcumin.
Bruck R; Ashkenazi M; Weiss S; Goldiner I; Shapiro H; Aeed H; Genina O; Helpern Z; Pines M
Liver Int; 2007 Apr; 27(3):373-83. PubMed ID: 17355460
[TBL] [Abstract][Full Text] [Related]
34. Celecoxib ameliorates portal hypertension of the cirrhotic rats through the dual inhibitory effects on the intrahepatic fibrosis and angiogenesis.
Gao JH; Wen SL; Yang WJ; Lu YY; Tong H; Huang ZY; Liu ZX; Tang CW
PLoS One; 2013; 8(7):e69309. PubMed ID: 23922700
[TBL] [Abstract][Full Text] [Related]
35. S-allyl-glutathione improves experimental liver fibrosis by regulating Kupffer cell activation in rats.
Takemura S; Azuma H; Osada-Oka M; Kubo S; Shibata T; Minamiyama Y
Am J Physiol Gastrointest Liver Physiol; 2018 Feb; 314(2):G150-G163. PubMed ID: 28971836
[TBL] [Abstract][Full Text] [Related]
36. FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis.
Verbeke L; Mannaerts I; Schierwagen R; Govaere O; Klein S; Vander Elst I; Windmolders P; Farre R; Wenes M; Mazzone M; Nevens F; van Grunsven LA; Trebicka J; Laleman W
Sci Rep; 2016 Sep; 6():33453. PubMed ID: 27634375
[TBL] [Abstract][Full Text] [Related]
37. Hepatoprotective effects of zingerone on carbon tetrachloride- and dimethylnitrosamine-induced liver injuries in rats.
Cheong KO; Shin DS; Bak J; Lee C; Kim KW; Je NK; Chung HY; Yoon S; Moon JO
Arch Pharm Res; 2016 Feb; 39(2):279-291. PubMed ID: 26667466
[TBL] [Abstract][Full Text] [Related]
38. Salvianolic acid B lowers portal pressure in cirrhotic rats and attenuates contraction of rat hepatic stellate cells by inhibiting RhoA signaling pathway.
Xu H; Zhou Y; Lu C; Ping J; Xu LM
Lab Invest; 2012 Dec; 92(12):1738-48. PubMed ID: 22986787
[TBL] [Abstract][Full Text] [Related]
39. The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells.
Vilaseca M; García-Calderó H; Lafoz E; García-Irigoyen O; Avila MA; Reverter JC; Bosch J; Hernández-Gea V; Gracia-Sancho J; García-Pagán JC
Hepatology; 2017 Jun; 65(6):2031-2044. PubMed ID: 28142199
[TBL] [Abstract][Full Text] [Related]
40. Extrahepatic angiogenesis hinders recovery of portal hypertension and collaterals in rats with cirrhosis resolution.
Hsu SJ; Tsai MH; Chang CC; Hsieh YH; Huang HC; Lee FY; Chuang CL; Hou MC; Lee SD
Clin Sci (Lond); 2018 Mar; 132(6):669-683. PubMed ID: 29449343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
